Navigation Links
Kristalose(R) Offers Prescription Alternative to MiraLAX(R) and Other PEG 3350 Products
Date:2/26/2008

Unique, crystalline laxative designed to enhance patient acceptance and

compliance

NASHVILLE, Tenn., Feb. 26 /PRNewswire/ -- Kristalose(R), a prescription laxative product that treats acute and chronic constipation, may be an effective option for physicians and pharmacists looking for a prescription alternative to MiraLAX(R) and generic PEG 3350 products. Marketed in the U.S. by Cumberland Pharmaceuticals, Kristalose(R) is now the only prescription- strength laxative available in a convenient powder packet.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080226/CLTU122 )

Previously available by prescription, MiraLAX(R) (polyethylene glycol 3350 or PEG 3350) became an over-the-counter (OTC) treatment for occasional constipation in early 2007. Due to U.S. Food and Drug Administration policy which does not allow the same formulation of a product to be marketed simultaneously as both a prescription and OTC drug, generic PEG 3350 products are now also becoming unavailable by prescription.(1) These generic products will not be available on the OTC market for at least three years following the MiraLAX(R) introduction due to marketing exclusivity granted by the FDA.

Physicians wrote more than 9 million prescriptions for MiraLAX(R) and generic PEG 3350 products in 2006 for treatment of constipation. As the PEG 3350 products are becoming unavailable by prescription, Cumberland believes Kristalose(R) offers a safe, effective alternative for physicians looking to retain prescriptive control for their patients.

Kristalose(R) (lactulose) for Oral Solution is a proprietary prescription laxative and the brand name for a unique crystalline form of lactulose that treats acute and chronic constipation. Available in pre-dosed packets, the drug dissolves quickly in four ounces of water, offering patients a virtually tasteless and grit-
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Health care incentive model offers collaborative approach
2. Eye-staining technique offers early detection for dry eye syndrome
3. Governor Rendell Offers adultBasic Coverage to 35,000 Uninsured Pennsylvanians
4. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
5. Psoriasis Cure Now offers Back to School Resources for Parents of Children with Psoriasis
6. ADDAS Awareness Campaign Offers Resources and Education to Adults Living with AD/HD and Professionals Working With Them
7. Regence Offers InterM to Fill Gap for the Uninsured
8. National Non-Profit Organization Offers Free Mental Health Services to Military and Military Families
9. Blue Cross Blue Shield of Michigan Offers New Approach to Customer Group Wellness
10. ProAssurance Group Offers Coverage for Community Based Hospitals in Michigan
11. Super Jake Foundation Offers Hope for Pediatric Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...gies (LCT) Limited has published evidence outlinin...e islet cells and insulin production in a human pa...ansplant. The scientific paper published in the ...journal Xenotransplantation outlines how LCT has d...
...gh source of nutrition for many people around the ...aten in several forms, it is the key ingredient fo.... With Easter just round the corner an animal righ...nch a campaign on Wednesday urging people not to e...
...ed several genetic risk factors leading to prostat...s the first real evidence of the genetic basis of ...e Keck School of Medicine at the University of Sou... the researchers of the study. "It gives us the ...
... their obsession for that ‘bronzed and beautiful’ ...nd, opine researchers. // According to a report p... of Public Health, the increases in people going i...ming. This is particularly so when considered in ...
Other Medicine News:Health News:Transplanted Pig Cells in Human Produce Insulin 2Health News:Transplanted Pig Cells in Human Produce Insulin 3Health News:Sultans of Suntans Warned 2
(Date:9/4/2008)...zing Patient Identification for Targeted Therapies... Treatment HUNTINGTON BEACH, Calif., and AMSTER... a world leader in molecular cancer diagnostics,t... diagnostic test that,allows physicians to quantit...e estrogen receptor (ER), progesterone receptor (P...
(Date:9/3/2008)..., Sept. 3 /- Simcere,Pharma...er and supplier of,branded generic pharmaceuticals...ech product Endu (also known as Endostar) in China...linical study., At the request of the SFDA, Simce...validate the safety and therapeutic efficacy of En...
(Date:9/3/2008)...ium and GENEVA, Sept. 3 /- Artelis SA... CHO based monoclonal antibody,production with the...ams,per liter. This record level was accomplished ...) a high-performance stable Selexis CHO,production...cientists at,Selexis SA using their proprietary Se...
(Date:9/3/2008)...s Operations, Updates Zingo Launch Progress and Ad... Conference Call Today at 11:30 am...wire-FirstCall/ -- Anesiva,Inc. (Nasdaq: ANSV ) ...operations to focus on commercial and late-stage p... a specialty pharmaceutical pain management,compan...
Breaking Medicine Technology:Agendia Launches TargetPrint(R) for Breast Cancer Patients 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Core People Partners to Expand Services 15673 1Core People Partners to Expand Services 15673 2Sutter Opens Countys First Non Hospital Based Nuclear Imaging Option 15668 1Sutter Opens Countys First Non Hospital Based Nuclear Imaging Option 15668 2Sutter Opens Countys First Non Hospital Based Nuclear Imaging Option 15668 3Final Data From the SEISMIC Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1662 1Final Data From the SEISMIC Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1662 2Final Data From the SEISMIC Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1662 3Final Data From the SEISMIC Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1662 4Scientists solve mystery of polyketide drug formation 15662 1Scientists solve mystery of polyketide drug formation 15662 2
...and CAPTURE 2 Findings Suggest Improved Outcomes i...h 26, 2007 /PRNewswire-FirstCall/ --,Positive 30-d...rotid stenting can be performed with positive resu...erience in real-world,(non-clinical trial) setting... surgery. Interim results from the first 1,500,pat...
...Program to be Presented at Keystone Scientific Mee.../PRNewswire-FirstCall/ -- Rigel today announced th...rology, will be presenting,on the company,s effort... patients with the Human Immunodeficiency Virus (H... Columbia on March,27th and 29th. Dr. Jenkins will...
Other Medicine Technology:Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 2Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 3Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 4Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV,Activity 2Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV,Activity 3
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
Medicine Products: